Intuitive Surgical (ISRG) Research & Development (2009 - 2026)

Intuitive Surgical has reported Research & Development for 18 years, with the latest figure at $370.6 million in Q2 2026.

• On a quarterly basis, Research & Development rose 18.29% year-over-year to $370.6 million in Q2 2026; TTM through Jun 2026 was $1.4 billion, a 16.91% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 14.54% from the prior year.
• Research & Development was $370.6 million for Q2 2026 at Intuitive Surgical, up from $361.9 million in the prior quarter.
• The five-year high for Research & Development was $370.6 million in Q2 2026, with the low at $207.3 million in Q2 2022.
• Average Research & Development over 5 years is $281.5 million, with a median of $282.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 33.1% in 2022, then gained 6.55% in 2023.
• Over 5 years, Research & Development stood at $244.1 million in 2022, then advanced by 6.55% to $260.1 million in 2023, then climbed by 13.3% to $294.7 million in 2024, then rose by 19.75% to $352.9 million in 2025, then climbed by 5.02% to $370.6 million in 2026.
• The last three Research & Development figures came in at $370.6 million (Q2 2026), $361.9 million (Q1 2026), and $352.9 million (Q4 2025), per Business Quant data.